Journal of Virology, August 2001, p. 7683-7691, Vol. 75, No. 16
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.16.7683-7691.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
The Wistar Institute, Philadelphia, Pennsylvania 19104
Received 13 February 2001/Accepted 9 May 2001
| |
ABSTRACT |
|---|
|
|
|---|
The RNA genome of human immunodeficiency virus type 1 (HIV-1) is converted into DNA after infection in order to integrate into the host cell DNA. However, a large number of these reverse-transcribed genomes remain unintegrated in the nucleus of infected cells. Currently, there are no data available about the intranuclear distribution pattern of unintegrated HIV-1 DNA in relation to nuclear structures as observed on the single-cell level. In the present study, we investigated the intranuclear fate of unintegrated viral DNA in cell lines expressing CD4 and coreceptors (HOS-CD4.CCR5 and U373-MAGI-CXCR4CEM) infected with HIV-1 (strain 89.6). We used a novel approach to distinguish in situ unintegrated from integrated viral DNA by performing fluorescent in situ hybridization on cells in which stress-induced chromosome condensation had been induced, a procedure that contracts chromosomes independent of the cell cycle. Cells infected for 15 h accumulated large amounts of HIV-1 DNA which was located between the condensed chromosome strands, allowing the identification of this viral DNA as unintegrated. In contrast, in HeLa/LAV, a cell line carrying integrated HIV-1 genomes, the great majority of viral DNA colocalized with the cellular DNA. We show that unintegrated HIV-1 DNA does not evenly distribute within the host cell nucleus but tends to aggregate into clusters containing many copies of the viral genomes. The formation of these DNA clusters was independent of viral DNA replication and thus appeared to result solely from multiple infections. The DNA aggregates remained in the nuclei of infected cells for at least 25 h after the infection was stopped. The emergence of transcription sites, which most likely denote sites of the integrated provirus, lagged clearly behind the accumulation of viral DNA. These transcription foci could not be linked to unintegrated DNA molecules, suggesting that this DNA type is unable to transcribe, at least at levels comparable to those of integrated DNA. Neither unintegrated HIV-1 DNA nor transcription foci nor integrated DNA was observed to associate with nuclear domain 10 (ND10), a nuclear structure known to represent the site where several DNA viruses replicate and transcribe. Also, HIV-1 does not modify ND10 at early or late times of infection. There was no specific association of HIV-1 transcripts with splicing factor SC35 domains, in contrast to what has been reported for a number of both cellular and viral genes. Surprisingly, unintegrated HIV-1 DNA was found to accumulate within or in close association with SC35 domains, demonstrating a specific distribution of the viral DNA within the host cell nucleus. Taken together, our results demonstrate that unintegrated proviral HIV-1 DNA does not randomly localize within infected cells but preferentially aggregates in the nucleus within SC35 domains.
| |
INTRODUCTION |
|---|
|
|
|---|
Upon infection, the RNA genome of human immunodeficiency virus type 1 (HIV-1) is reverse transcribed into a linear, double-stranded DNA molecule which is destined to integrate into the cellular genome to produce new viral RNA. The proteins involved in reverse transcription are assembled in the cytoplasm together with the viral genome into the preintegration complex, which is actively transported into the nucleus through the nuclear pores, a process unique to lentiviruses which allows them to access the host cell DNA independent of the cell cycle (10). Nuclear localization signals within the matrix, Vpr, and integrase proteins have been described (for a review, see references 9 and 25), and recently a central DNA flap of the HIV-1 genome was reported to be essential for nuclear uptake (62). Once in the nucleus, the proviral DNA has to integrate into the host cell genome for viral replication. The degree to which integration is a prerequisite for viral transcription at all has been widely discussed, but it appears that productive infection, at least, requires integrated viral genomes (12, 13, 21, 22, 54, 56, 59).
However, not all of the reverse-transcribed HIV-1 DNA will actually become integrated into the chromosomal DNA. A large proportion of the viral DNA molecules that are synthesized after infection remain unintegrated, a phenomenon that seems to be common to all cytopathic animal retroviruses (for a review, see references 8 and 14). Unintegrated HIV-1 DNA has gained clinical importance because its accumulation within infected cells might be associated with cytopathic effects or might be used as a marker for disease progression (28, 46, 47, 49, 50, 61). Whereas the cellular distribution of HIV-1 RNA has been investigated in several studies by in situ hybridization (6, 7, 23, 24, 41, 63), to our knowledge no data are currently available about the intranuclear localization of HIV-1 DNA, integrated as well as unintegrated, in relation to nuclear domains. Two types of domains within the cell nucleus are of particular interest when studying the distribution of viral genomes and transcripts, i.e., nuclear domain 10 (ND10) (also termed the promyelocytic leukemia protein [PML] oncogenic domain or PML body) and SC35 domains (also known as interchromatinic granule clusters).
The ND10 contain several interferon-upregulated proteins such as PML and Sp100 and have gained increasing interest as the nuclear site where DNA viruses start transcription and replication. Although these viruses apparently enter the nucleus randomly, they transcribe and replicate only in immediate association with ND10 (for a review, see reference 37). Moreover, several DNA viruses have the ability to modify or disperse ND10 after starting their transcription at this site (30, 31, 38). RNA viruses also appear to interact with ND10. Hepatitis delta virus, a satellite virus of human hepatitis B virus, aggregates its antigenomic RNA preferentially at ND10 and thereby causes a segregation of ND10 proteins (3). Overexpression of PML, an essential constituent of ND10, reduces replication of vesicular stomatitis virus and influenza A virus (15), suggesting that ND10 are involved in an antiviral defense mechanism.
SC35 domains represent the second nuclear component which is often used as a landmark in intranuclear localization studies. These domains are defined by aggregations of splicing factor SC35 (26) but also contain other components of the splicing machinery (for a review, see reference 43). SC35 domains are located in the interchromosomal space; transcripts of many genes, both cellular and viral, show a specific type of association with this domain (20, 31, 40, 55). The relationship between HIV-1 transcripts and SC35 domains has been studied mainly by transfecting cells with plasmids containing the proviral genome. Unspliced HIV-1 RNA and SC35 domains appear to be more or less randomly distributed within the nucleus without being specifically associated with each other (6, 7, 63), although a certain degree of specific association of both components has been described (23). In contrast, spliced HIV-1 RNAs may show a different localization pattern by accumulating within the splicing factor domains as has been shown for the multiply spliced transcripts encoding the tat gene (6).
In this report, we studied the fate of unintegrated HIV-1 DNA within the nuclei of infected cells by in situ hybridization and compared its nuclear distribution with the localization pattern of integrated DNA and viral transcripts as well as the distribution of ND10 and SC35 domains. Our studies were performed at a single-cell level allowing the direct visualization of viral genomes instead of studying whole cell populations. Also, we freshly infected cells with infectious virus particles rather than using transfections, as in earlier studies addressing the intranuclear distribution of HIV-1 RNA. To distinguish in situ unintegrated from integrated HIV-1 DNA, we employed stress-induced chromosome condensation (SICC) (51), which is a combination of heat shock and osmotic stress that leads to the contraction of interphase chromosomes within 15 to 20 min and thus reveals the interchromosomal space which is otherwise not visible during interphase. We show that unintegrated DNA accumulates between the chromosomes, a distribution pattern that is in sharp contrast to the specific chromosomal localization of integrated DNA. We demonstrate that unintegrated DNA aggregates into clusters and accumulates in the nucleus before viral transcripts are detectable. In contrast to several other viruses, neither HIV-1 RNA nor DNA affiliates with ND10. However, unintegrated HIV-1 DNA genomes, but not integrated genomes or transcription sites, specifically associate with SC35 domains. The implications of these localization patterns with regard to the possible cytopathic effect of unintegrated HIV-1 DNA are discussed.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cell culture and infection. The following cell lines were obtained from the National Institutes of Health (NIH) AIDS Research and Reference Program: HeLa/LAV, a permanently HIV-1-infected HeLa cell line that carries integrated viral genomes (5); HOS-CD4.CCR5, a cell line that expresses CD4 and CCR5 (19); and U373-MAGI-CXCR4CEM, which expresses CD4 and CXCR4 (58). Cells were grown in Dulbecco's modified Eagle medium supplemented with 10% fetal bovine serum and 1% penicillin-streptomycin at 37°C in a humidified atmosphere containing 5% CO2. For the maintenance of HOS-CD4.CCR5 and U373-MAGI-CXCR4CEM cells, puromycin (Sigma) was added to the medium at a concentration of 1 µg/ml.
The dualtropic HIV-1 strain 89.6 (16) was used for the infection of HOS-CD4.CCR5 and U373-MAGI-CXCR4CEM cells. Viruses were produced in U937 cells, and the culture supernatants were collected, supplemented with MgCl2 (5.4 mM), and treated with DNase I (300 U/ml; Boehringer) for 30 min at room temperature. The virus stocks had a 50% tissue culture infective dose of 5 × 103/ml as determined by p24 staining of U373-MAGI-CXCR4CEM cells infected for 2 days with a 1:3 serial dilution of virus stock. For infection, HOS-CD4.CCR5 and U373-MAGI-CXCR4CEM cells were grown on glass coverslips at a density of 200,000 cells per well in 24-well plates, and culture medium was replaced for 15 h with HIV-1 inoculum at a multiplicity of infection of 0.005. After infection, cells were washed three times with sterile phosphate-buffered saline (PBS) and either fixed immediately or further cultivated in virus-free medium for various times. In some experiments, the infection was carried out in the presence of aphidicolin at 10 µg/ml (ICN) or zidovudine (AZT)-5'-triphosphate at variable concentrations (obtained through the NIH AIDS Research and Reference Program from R. F. Schinazi). SICC was induced as previously described (51). In brief, cells grown on coverslips were incubated at 41°C for 15 to 20 min while covered only with a thin film of medium. Cells were then immediately fixed and processed as described below.Immunofluorescence and microscopy. ND10 were visualized with rabbit sera against Sp100 or PML (34), and SC35 domains were detected using a monoclonal antibody against splicing factor SC35 (Sigma-Aldrich) (26). Monoclonal antibody HIV.OT 34A specific for p24 was obtained from ICN.
Cells were grown on coverslips in 24-well plates and fixed in 1% paraformaldehyde (PFA) for 10 min at room temperature. The fixed cells were permeabilized by incubation in 0.2% Triton X-100 (20 min on ice) and incubated with primary (1 h) and Texas red-labeled secondary (30 min) antibodies (all solutions were in PBS). Finally, cells were stained for DNA with Hoechst 33258 (0.5 µg/ml) and mounted with Fluoromount G (Fisher Scientific). Confocal images of cells were obtained using a Leica confocal laser scanning microscope. The two channels were recorded simultaneously if no cross talk was detected. In the case of strong fluorescein isothiocyanate (FITC) labeling, sequential images were acquired with more-restrictive filters to prevent possible breakthrough of the FITC signal into the red channel. Both acquisition modes resulted in the same images. The Leica enhancement software was used in balancing the signal strength, and images were scanned eightfold to separate signal from noise. Alternatively, cells were analyzed with a Leitz Fluovert inverted microscope equipped with a digital camera. Images were obtained with software from QED Imaging (Pittsburgh, Pa.).FISH.
Cells were fixed in 4% PFA or, when fluorescent in
situ hybridization (FISH) was combined with immunocytochemistry, were
first immunostained as described above and then refixed in 4% PFA to cross-link bound antibodies (39). Cells were then
permeabilized in 0.2% Triton X-100 and, for detection of DNA, treated
with RNase (Boehringer) at a concentration of 100 µg/ml in PBS for 30 min at 37°C. After equilibration in 2× SSC (1× SSC is 0.15 M NaCl plus 0.015 M sodium citrate), cells were dehydrated in an ethanol series (70, 80, and 100% ethanol for 3 min each at
20°C), air dried, and incubated overnight at 37°C with the hybridization mixture. Plasmid p89.6 FS
(kindly provided by R. Collman)
(16), which contains the HIV-1 89.6 genome, was labeled with
biotin-16-dUTP by nick translation and used as a probe. The DNase
concentration was adjusted to yield probe DNA with a fragment length of
200 to 500 bp. Probe DNA was dissolved at a concentration of 10 ng/µl in 50% formamide in 2× SSC containing 10% dextran sulfate, 100 ng of
salmon sperm DNA (Gibco BRL)/µl, 1 µg of yeast tRNA (Sigma)/µl, and 0.5 mg of cot1 DNA (Gibco BRL)/µl. For DNA detection, probe and
cells were simultaneously heated at 94°C for 4 min to denature DNA.
To detect RNA, only the probe DNA was denatured at 90°C for 5 min.
After hybridization, specimens were washed at 37°C with 55%
formamide in 2× SSC (twice for 15 min each time), 2× SSC (10 min), and 0.25× SSC (twice for 5 min each time). Hybridized probes were labeled with FITC-avidin (1:500 in 4× SSC plus 0.5% bovine serum
albumin; Vector Laboratories), and signals were amplified with
biotinylated anti-avidin (1:250; Vector Laboratories), followed by
another round of FITC-avidin staining. Finally, cells were equilibrated
in PBS, stained for DNA with Hoechst 33258 (0.5 µg/ml) or
propidium iodide (1 µg/ml), and mounted with Fluoromount G (Fisher Scientific).
| |
RESULTS |
|---|
|
|
|---|
Unintegrated HIV-1 DNA accumulates within the interchromosomal
space.
Flat, adherent cell lines are far more amenable to the in
situ hybridization procedure than round suspension cells such as lymphocytes. To visualize HIV-1 genomes by FISH, we therefore used cell
lines derived from human glioblastoma cells
(U373-MAGI-CXCR4CEM) and human osteosarcoma cells
(HOS-CD4.CCR5) which express CD4 and the coreceptors CXCR4 and CCR5,
respectively. Staining with antibodies against p24 2 to 3 days after a
15-h infection with HIV-1 strain 89.6 demonstrated high infection rates
in both cell lines with up to 95% p24-positive cells (data not shown).
Generally, U373-MAGI-CXCR4CEM cells yielded
slightly higher infection rates than HOS-CD4.CCR5 cells. When
hybridized with an HIV-1-specific probe to detect reverse-transcribed
DNA, cells incubated for 15 h in HIV-1-containing culture
supernatant usually displayed 10 to 50 nuclear signals of variable size
(Fig. 1A). As controls, FISH was performed with uninfected cells, or infected
cells were hybridized with a probe not specific for HIV (biotinylated
bacteriophage
DNA). In either case, no nuclear or cytoplasmic
signals could be detected. DNase treatment prior to hybridization also
eliminated any detectable signals, demonstrating that all visible spots
actually represented HIV-1 DNA and not viral RNA. We further infected
cells in the presence of AZT-5'-triphosphate at concentrations of 0.01, 0.1, and 1 µM to see whether the detected viral DNA molecules were
synthesized de novo by reverse transcription. As expected, AZT-treated
cells showed a dose-dependent reduction of detectable DNA signals. Most
nuclei of cells treated with 1 µM AZT lacked viral DNA. In most of
the untreated cells, viral DNA could be found only within the nucleus,
whereas cells which usually displayed 3 to 10 cytoplasmic signals were
observed only occasionally (data not shown).
|
Nuclear unintegrated HIV-1 DNA aggregates into clusters.
A
striking feature of nuclear HIV-1 DNA in HOS-CD4.CCR5 and
U373-MAGI-CXCR4CEM cells was the variable size of
signals obtained by FISH, since the size of in situ signals strictly
correlates with size and/or number of the target molecules.
Unintegrated DNA in both cell lines could be visualized as dots with a
wide range of different sizes, often in the form of irregularly shaped aggregates up to several microns in diameter (Fig. 1F). In contrast, integrated viral DNA in HeLa/LAV cells was visible as more or less
uniform signals of smaller size (Fig. 1B). Quantification by counting
the number of pixels for each signal confirmed that integrated DNA was
represented only by small-sized signals (mostly 2 to 4 pixels with an
average signal size of 2.7 pixels), whereas unintegrated DNA yielded
both small and large dots without any obvious size limit (average
signal size, 7.8 pixels; the largest signal observed comprised 155 pixels) (Fig. 2). Since integrated DNA
corresponds to single proviral genomes, we assume that the small
signals observed in HeLa/LAV cells (two to four pixels) represent the
size of one individual HIV-1 DNA molecule. Therefore, about half of the
signals from unintegrated viral DNA (53%) appear to represent single
HIV-1 genomes, whereas 47% of the DNA dots seem to be composed of
multiple, closely associated copies of unintegrated DNA. The great
majority of the total amount of unintegrated DNA molecules is therefore
aggregated as clusters in the nucleus. The mean size of those DNA
clusters correlated to the length of the infection time, with an
average of 3.0 pixels per signal after 6 h of infection and 7.8 pixels per signal after 15 h of infection in HOS-CD4.CCR5 cells,
indicating that viral DNA entering the nucleus is continuously forming
aggregates.
|
HIV-1 DNA and transcripts are not specifically associated with ND10. To study the localization of HIV-1 genomes in relation to ND10, we performed immunohistochemistry combined with FISH with infected HOS-CD4.CCR5 and HeLa/LAV cells. HOS-CD4.CCR5 cells possess considerably larger ND10 than U373-MAGI-CXCR4CEM cells and thus allowed an easier identification of the ND10 domain by immunostaining. When we identified ND10 with antibodies against PML or Sp100 and simultaneously stained unintegrated HIV-1 DNA by FISH, cells which contained HIV-1 DNA still possessed intact ND10, whose number and appearance were not different from those in uninfected cells. ND10 remained unaffected both at early times after infection (30 min to 6 h) and after infection periods of 15 to 18 h. Unintegrated DNA was not specifically associated with ND10, and only occasionally were ND10 and viral DNA found in close association, obviously reflecting a random distribution of both components (Fig. 1H). Thus, in contrast to DNA viruses, HIV-1 DNA neither destroys nor associates with ND10. Since most of the unintegrated HIV-1 DNA probably is transcriptionally inactive or supports only low-level transcription, we wondered whether transcribing (i.e., integrated) viral genomes behaved differently and interacted with ND10. Visualization of total HIV-1 RNA by FISH of infected HOS-CD4.CCR5 cells usually revealed one to four RNA foci, most likely denoting sites of integrated HIV-1 genomes, and lower concentrations of transcripts more or less evenly distributed within the nucleus except for the nucleoli which lacked any visible signals. As in the case of HIV-1 DNA, cells positive for HIV-1 transcripts possessed intact ND10, as shown by costaining for PML or Sp100. Also, the transcription foci could not be found to be specifically associated with ND10 (Fig. 1G). We furthermore tested viral DNA in HeLa/LAV cells, i.e., integrated DNA, for its association with ND10. As expected from the absence of transcription sites from ND10 in HOS-CD4.CCR5 cells, integrated proviral DNA also did not show any specific localization pattern in relation to ND10 (data not shown). We conclude that HIV-1, in contrast to many other viruses, does not interact with ND10 irrespective of its status as DNA or RNA genome.
Unintegrated HIV-1 DNA, but not RNA, associates with SC35 domains. The interaction between unspliced HIV-1 transcripts and SC35 domains has been previously investigated, mostly by transfection of cells with plasmids containing the HIV-1 genome. Both colocalization (23) and a random distribution of both components (6, 7, 63) have been described. We reexamined the behavior of HIV-1 RNA in relation to SC35 domains in infected instead of transfected cells using a probe that comprises the whole HIV-1 genome and also tested whether HIV-1 DNA interacted with this domain. Concentrations of viral RNA denoting integrated genomes after infection of HOS-CD4.CCR5 or U373-MAGI-CXCR4CEM cells did not specifically associate with SC35 domains. Although about 50% of the RNA foci were observed in direct contact with the splicing factor domains, this finding obviously reflects a random distribution of both components, given the relatively large nuclear volume occupied by these domains (Fig. 1I). Nucleoli lacked both SC35 domains and detectable HIV-1 transcripts and therefore appeared as empty holes within the nucleus (Fig. 1I). Likewise, hybridization signals in HeLa/LAV cells representing integrated HIV genomes were also associated only in a random fashion with SC35 domains (data not shown).
In contrast, unintegrated viral DNA showed quite a different distribution pattern. Approximately 95% of the DNA aggregations were either associated with or completely enclosed in the SC35 domains (Fig. 1J). This affiliation was independent of the size of the DNA signals, i.e., both small signals probably representing single copies of unintegrated DNA and large DNA clusters were found in direct contact with the splicing factor domains. Also, cells infected at lower virus concentrations displayed a lower number of signals without a change in their distribution pattern. Unintegrated HIV-1 DNA therefore appears to be targeted to SC35 domains where it accumulates and forms aggregates.Accumulation of HIV-1 DNA precedes viral transcription.
Although unintegrated HIV-1 DNA is probably not able to support
productive viral replication, several studies suggest that it is able
to transcribe (for a review, see reference 14). Since we
observed high levels of unintegrated DNA in infected cells, we wondered
how much the accumulation of unintegrated DNA correlated with the
production of HIV-1 RNA. We incubated
U373-MAGI-CXCR4CEM cells in HIV-1-containing
culture supernatant for 15 h and then further in virus-free
medium. Viral DNA could be detected in 15% of the cells 6 h after
the infection was started; however, no HIV-1 transcripts were visible
at this time point. After a 15-h incubation with HIV-1, virtually all
nuclei contained viral DNA, whereas viral RNA was observed in only 13%
of the cells (Fig. 1K and L). Forty hours after infection, the number
of HIV-1 RNA-positive cells finally reached levels similar to those of
cells displaying viral DNA with 95% RNA-positive and 100%
DNA-positive cells (Fig. 3). These
findings suggest that the production of HIV-1 transcripts is a
relatively slow process compared to the accumulation of viral DNA. Even
after 40 h, although 100% of the cells contained high numbers of
viral DNA for at least 25 h, 5% of the cells still lacked
detectable transcripts.
|
| |
DISCUSSION |
|---|
|
|
|---|
Since efforts are currently being made to develop integrase inhibitors for AIDS therapy (18, 48, 52), a model system that allows the visualization of unintegrated HIV-1 DNA at the single-cell level might represent a useful tool to study the dynamics of the integration process. Here, we employed a novel method to distinguish in situ integrated from unintegrated HIV-1 DNA. Cells treated to perform SICC (51) contract their chromatin strands and thus clearly show the two major nuclear compartments, i.e., chromosomes and the interchromosomal space. In contrast to mitotic cells, SICC-treated cells are still in interphase and thus retain their nuclear envelope, allowing a distinction between nucleus and cytoplasm. FISH revealed the great majority of the nuclear proviral genomes either in the interchromosomal space in infected HOS-CD4.CCR5 and U373-MAGI-CXCR4CEM cells or colocalizing with the cellular DNA in HeLa/LAV cells. Therefore, using this approach, we showed that nearly all HIV-1 DNA visible in freshly infected cells represents the unintegrated form. Here, we demonstrated specific localization features of unintegrated HIV-1 DNA, i.e., it aggregated into clusters within the nucleus and localized within or in close association with SC35 domains but showed no affiliation with ND10.
Transcription and replication of many DNA viruses is visible only at ND10. This localization pattern is believed to represent a cellular segregation mechanism to confine or restrict these viral activities within the nucleus. This view is supported by the fact that ND10 contain several interferon-upregulated proteins and that herpesviruses as well as adenovirus type 5 destroy or modify ND10 after having started their replication at these sites. Alternatively, ND10 might represent nuclear sites required by viruses to replicate (for a review, see reference 37). These nuclear domains have therefore gained interest as a possible target to interfere with or manipulate viral replication. However, with HIV-1 we never observed unintegrated or integrated DNA or viral transcription foci affiliated with ND10, except for what appeared to be random associations. This domain, therefore, appears not to be directly involved in the replicative cycle of HIV.
In contrast, unintegrated HIV-1 DNA showed a clear association with splicing factor domains containing the marker protein SC35. Over 90% of the unintegrated DNA molecules were observed to colocalize with SC35 domains, whereas only about 50% of viral transcription foci (or integrated viral DNA) were found to associate with this domain. The association between HIV-1 transcription sites and SC35 domains appears to be the result of a random distribution of both structures, due to the relatively large nuclear volume occupied by the splicing factor domains. In contrast, the almost exclusive localization of unintegrated DNA in or at these domains obviously reflects a nonrandom distribution pattern. A similar behavior has been described for microinjected simian virus 40 DNA, which also accumulated within the SC35 domains (17). However, viral DNA is not generally targeted into SC35 domains, although viral transcripts may show a clear association with this structure (31). The specificity of the colocalization of HIV-1 DNA with SC35 domains becomes even more evident when compared with the nuclear distribution of Epstein-Barr virus episomes. As we have shown previously, the circular, unintegrated genomes of Epstein-Barr virus localize almost exclusively outside of SC35 domains in latently infected cells (4). Moreover, they do not form aggregates but remain as individual molecules in the host cell nucleus, in contrast to unintegrated HIV-1 DNA, which is prone to form clusters containing many copies of the viral genomes.
It is noteworthy in this context that morphological changes in the three-dimensional structure of SC35 domains have been described for HIV-1-infected cells (36). SC35 domains contain high concentrations of splicing factors and small nuclear RNAs (snRNAs), as well as transcription factors, although splicing itself appears not to occur within these domains. SC35 domains are therefore believed to be necessary for the regulation of splicing factor ratios and concentrations, for recycling of splicing components, and for the assembly of the transcription and processing machinery (42-44). The presence of large numbers of unintegrated HIV-1 molecules within this domain could therefore interfere with the regulation of splicing factor concentrations in the nucleus.
The large amount of unintegrated HIV-1 DNA in the nuclei of infected cells is generally believed to be the result of multiple infections (50, 53). When we infected cells in the presence of the DNA replication inhibitor aphidicolin, replication-arrested and control cells displayed equal amounts of unintegrated DNA, also indicating that infection but not viral DNA replication is the only source for HIV-1 DNA. The first appearance of reverse-transcribed DNA has been reported at 4 h (2, 32) or even at 1 to 2 h (27) after infection. Together with our results showing that after 6 h viral DNA is already present in 15% of U373-MAGI-CXCR4CEM cells, these data indicate that the generation of HIV-1 DNA represents a rapid process probably starting immediately after infection. In a lymphocyte cell line, the amount of viral DNA was found to gradually increase under single-cycle growth conditions for HIV-1 until a peak was reached at 8 to 12 h postinfection (32). Interestingly, the amount of HIV-1 DNA decreased after having reached the peak (32), whereas in our system the viral DNA appeared to be more or less stable at least until 40 h after infection. The number of unintegrated DNA molecules in infected lymphocytes has been estimated to be between 20 and more than 400 copies per cell (32, 45, 53), similar to our observations of infected HOS-CD4.CCR5 and U373-MAGI-CXCR4CEM cells. The advantage of in situ hybridization combined with SICC is the direct visualization of unintegrated HIV-1 DNA molecules, although due to the aggregation of the viral DNA, the exact number of molecules contained in clusters can only be roughly estimated.
After a 15-h infection, virtually all U373-MAGI-CXCR4CEM cells contained unintegrated DNA, but only a relatively small fraction of these cells displayed viral transcripts. Our FISH procedure allows the visualization of individual full-length HIV-1 transcripts; however, smaller RNA species may escape detection at the single-molecule level. We therefore conclude that unintegrated DNA molecules are unable to produce full-length transcripts or, alternatively, high concentrations of smaller transcripts which would be equally detectable. Since the first appearance of viral RNA from certain genes (tat, nef) could already be observed by PCR 2 to 3 h after infection of H9 cells (27), the generation of low levels of small RNA species of subgenomic size may have remained undetectable in our study. The number of transcription foci (which most likely denote the site of the integrated provirus) was considerably lower than the number of viral DNA molecules; integration, as a prerequisite for detectable transcription, therefore appeared to be a relatively rare event. Also, the generation of detectable transcripts clearly lagged behind the first appearance of unintegrated DNA, suggesting that integration or at least production of full-length viral RNA represents a relatively slow process. Using a coculture system for infection of MT4 cells, it has been estimated that at least one third of all input reverse-transcribed DNA will become integrated (2), whereas our data suggest a much lower integration rate. We further observed a considerable increase (from 15 to 95%) of cells containing viral transcripts in the absence of HIV-1-containing supernatants after an initial infection, indicating either that previously formed unintegrated DNA molecules (present in 100% of the U373-MAGI-CXCR4CEM cells) may serve as a reservoir for later integration events or that integrated DNA may not immediately start transcription, at least at high levels. Earlier reports support both possibilities. In quiescent T cells, unintegrated DNA was found to retain the ability to integrate later upon T-cell activation in vitro (11). In a lymphocyte cell line with single-cycle growth conditions for HIV-1, the level of unspliced transcripts remained low until after 24 h of infection; whereas subgenomic RNAs, which might be less easier to detect by FISH, accumulated earlier (32). Although there seems to exist a considerable amount of integration-competent DNA, it has also been shown that newly synthesized viral DNA may be highly labile at least before being imported into the nucleus (33, 60). This might account for our observation that HIV-1 DNA was only occasionally detectable within the cytoplasm despite being present in the nucleus in large amounts. It remains to be determined whether future therapeutic interventions which block the HIV-1 integrase will be affected by a stable pool of integration-competent DNA.
| |
ACKNOWLEDGMENTS |
|---|
This study was supported by NIH grants AI 41136 and GM 57599, NSF grant MCB9728398, the G. Harold and Leila Y. Mathers Charitable Foundation, the W. W. Smith Foundation (G.G.M.), NIH grant AI 47760, and by M. Stengel-Miller and H. Miller, Jr. (L.J.M.). NIH core grant CA-10815 is acknowledged for the support of the microscopy and sequencing facility, and the Philadelphia Foundation funded the BSL-3 laboratory.
We thank R. Collman for providing plasmid p89.6 FS
.
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: The Wistar Institute, 3601 Spruce St., Philadelphia, PA 19104. Phone: (215) 898-3817. Fax: (215) 898-3868. E-mail: maul{at}wistar.upenn.edu.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ahn, J. H.,
W. J. Jang, and G. S. Hayward.
1999.
The human cytomegalovirus IE2 and UL112-113 proteins accumulate in viral DNA replication compartments that initiate from the periphery of promyelocytic leukemia protein-associated nuclear bodies (PODs or ND10).
J. Virol.
73:10458-10471 |
| 2. | Barbosa, P., P. Charneau, N. Dumey, and F. Clavel. 1994. Kinetic analysis of HIV-1 early replicative steps in a coculture system. AIDS Res. Hum. Retrovir. 10:53-59[Medline]. |
| 3. |
Bell, P.,
R. Brazas,
D. Ganem, and G. G. Maul.
2000.
Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10.
J. Virol.
74:5329-5336 |
| 4. |
Bell, P.,
P. M. Lieberman, and G. G. Maul.
2000.
Lytic but not latent replication of Epstein-Barr virus is associated with PML and induces sequential release of nuclear domain 10 proteins.
J. Virol.
74:11800-11810 |
| 5. | Berg, J., B. Doe, K. S. Steimer, and M. Wabl. 1991. HeLa-LAV, an epithelial cell line stably infected with HIV-1. J. Virol. Methods 34:173-180[CrossRef][Medline]. |
| 6. | Berthold, E., and F. Maldarelli. 1996. cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations. J. Virol. 70:4667-4682[Abstract]. |
| 7. | Boe, S. O., B. Bjorndal, B. Rosok, A. M. Szilvay, and K. H. Kalland. 1998. Subcellular localization of human immunodeficiency virus type 1 RNAs, Rev, and the splicing factor SC-35. Virology 244:473-482[CrossRef][Medline]. |
| 8. | Brown, P. O. 1997. Integration, p. 161-203. In J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y. |
| 9. | Bukrinsky, M. I., and O. K. Haffar. 1999. HIV-1 nuclear import: in search of a leader. Front. Biosci. 4:D772-D781[Medline]. |
| 10. |
Bukrinsky, M. I.,
N. Sharova,
M. P. Dempsey,
T. L. Stanwick,
A. G. Bukrinskaya,
S. Haggerty, and M. Stevenson.
1992.
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.
Proc. Natl. Acad. Sci. USA
89:6580-6584 |
| 11. |
Bukrinsky, M. I.,
T. L. Stanwick,
M. P. Dempsey, and M. Stevenson.
1991.
Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection.
Science
254:423-427 |
| 12. |
Cara, A.,
A. Cereseto,
F. Lori, and M. S. Reitz, Jr.
1996.
HIV-1 protein expression from synthetic circles of DNA mimicking the extrachromosomal forms of viral DNA.
J. Biol. Chem.
271:5393-5397 |
| 13. | Cara, A., F. Guarnaccia, M. S. Reitz, Jr., R. C. Gallo, and F. Lori. 1995. Self-limiting, cell type-dependent replication of an integrase-defective human immunodeficiency virus type 1 in human primary macrophages but not T lymphocytes. Virology 208:242-248[CrossRef][Medline]. |
| 14. | Cara, A., and M. S. Reitz, Jr. 1997. New insight on the role of extrachromosomal retroviral DNA. Leukemia 11:1395-1399[CrossRef][Medline]. |
| 15. |
Chelbi-Alix, M. K.,
F. Quignon,
L. Pelicano,
M. H. Koken, and H. de The.
1998.
Resistance to virus infection conferred by the interferon-induced promyelocytic leukemia protein.
J. Virol.
72:1043-1051 |
| 16. |
Collman, R.,
J. W. Balliet,
S. A. Gregory,
H. Friedman,
D. L. Kolson,
N. Nathanson, and A. Srinivasan.
1992.
An infectious molecular clone of an unusual macrophage-tropic and highly cytopathic strain of human immunodeficiency virus type 1.
J. Virol.
66:7517-7521 |
| 17. | Dean, D. A. 1997. Import of plasmid DNA into the nucleus is sequence specific. Exp. Cell Res. 230:293-302[CrossRef][Medline]. |
| 18. | De Clercq, E. 2000. Novel compounds in preclinical/early clinical development for the treatment of HIV infections. Rev. Med. Virol. 10:255-277[CrossRef][Medline]. |
| 19. | Deng, H., R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R. E. Sutton, C. M. Hill, C. B. Davis, S. C. Peiper, T. J. Schall, D. R. Littman, and N. R. Landau. 1996. Identification of a major co-receptor for primary isolates of HIV-1. Nature 381:661-666[CrossRef][Medline]. |
| 20. | Dirks, R. W., E. S. de Pauw, and A. K. Raap. 1997. Splicing factors associate with nuclear HCMV-IE transcripts after transcriptional activation of the gene, but dissociate upon transcription inhibition: evidence for a dynamic organization of splicing factors. J. Cell Sci. 110:515-522[Abstract]. |
| 21. | Engelman, A., G. Englund, J. M. Orenstein, M. A. Martin, and R. Craigie. 1995. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69:2729-2736[Abstract]. |
| 22. | Englund, G., T. S. Theodore, E. O. Freed, A. Engleman, and M. A. Martin. 1995. Integration is required for productive infection of monocyte-derived macrophages by human immunodeficiency virus type 1. J. Virol. 69:3216-3219[Abstract]. |
| 23. | Favaro, J. P., K. T. Borg, S. J. Arrigo, and M. G. Schmidt. 1998. Effect of Rev on the intranuclear localization of HIV-1 unspliced RNA. Virology 249:286-296[CrossRef][Medline]. |
| 24. | Favaro, J. P., F. Maldarelli, S. J. Arrigo, and M. G. Schmidt. 1999. Effect of rev on the cytoplasmic localization of intron-containing human immunodeficiency virus type 1 RNA. Virology 255:237-249[CrossRef][Medline]. |
| 25. | Fouchier, R. A., and M. H. Malim. 1999. Nuclear import of human immunodeficiency virus type-1 preintegration complexes. Adv. Virus Res. 52:275-299[Medline]. |
| 26. | Fu, X. D., and T. Maniatis. 1990. Factor required for mammalian spliceosome assembly is localized to discrete regions in the nucleus. Nature 343:437-441[CrossRef][Medline]. |
| 27. | Hewlett, I. K., S. J. Geyer, C. A. Hawthorne, M. Ruta, and J. S. Epstein. 1991. Kinetics of early HIV-1 gene expression in infected H9 cells assessed by PCR. Oncogene 6:491-493[Medline]. |
| 28. | Holter, W., A. B. Rabson, C. D. Corsico, and B. H. Howard. 1991. Sequence-specific toxicity of transfected retroviral DNA. Exp. Cell Res. 193:54-58[CrossRef][Medline]. |
| 29. | Ikegami, S., T. Taguchi, M. Ohashi, M. Oguro, H. Nagano, and Y. Mano. 1978. Aphidicolin prevents mitotic cell division by interfering with the activity of DNA polymerase-alpha. Nature 275:458-460[CrossRef][Medline]. |
| 30. |
Ishov, A. M., and G. G. Maul.
1996.
The periphery of nuclear domain 10 (ND10) as site of DNA virus deposition.
J. Cell Biol.
134:815-826 |
| 31. |
Ishov, A. M.,
R. M. Stenberg, and G. G. Maul.
1997.
Human cytomegalovirus immediate early interaction with host nuclear structures: definition of an immediate transcript environment.
J. Cell Biol.
138:5-16 |
| 32. |
Kim, S. Y.,
R. Byrn,
J. Groopman, and D. Baltimore.
1989.
Temporal aspects of DNA and RNA synthesis during human immunodeficiency virus infection: evidence for differential gene expression.
J. Virol.
63:3708-3713 |
| 33. |
Korin, Y. D., and J. A. Zack.
1999.
Nonproductive human immunodeficiency virus type 1 infection in nucleoside-treated G0 lymphocytes.
J. Virol.
73:6526-6532 |
| 34. | Korioth, F., G. G. Maul, B. Plachter, T. Stamminger, and J. Frey. 1996. The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp. Cell Res. 229:155-158[CrossRef][Medline]. |
| 35. | Lukonis, C. J., and S. K. Weller. 1997. Formation of herpes simplex virus type 1 replication compartments by transfection: requirements and localization to nuclear domain 10. J. Virol. 71:2390-2399[Abstract]. |
| 36. | Luznik, L., M. E. Martone, G. Kraus, Y. Zhang, Y. Xu, M. H. Ellisman, and F. Wong-Staal. 1995. Localization of human immunodeficiency virus Rev in transfected and virus-infected cells. AIDS Res. Hum. Retrovir. 11:795-804[Medline]. |
| 37. | Maul, G. G. 1998. Nuclear domain 10, the site of DNA virus transcription and replication. Bioessays 20:660-667[CrossRef][Medline]. |
| 38. |
Maul, G. G.,
H. H. Guldner, and J. G. Spivack.
1993.
Modification of discrete nuclear domains induced by herpes simplex virus type 1 immediate early gene 1 product (ICP0).
J. Gen. Virol.
74:2679-2690 |
| 39. | Maul, G. G., A. M. Ishov, and R. D. Everett. 1996. Nuclear domain 10 as preexisting potential replication start sites of herpes simplex virus type-1. Virology 217:67-75[CrossRef][Medline]. |
| 40. |
Melcak, I.,
S. Cermanova,
K. Jirsova,
K. Koberna,
J. Malinsky, and I. Raska.
2000.
Nuclear pre-mRNA compartmentalization: trafficking of released transcripts to splicing factor reservoirs.
Mol. Biol. Cell
11:497-510 |
| 41. |
Michienzi, A.,
L. Cagnon,
I. Bahner, and J. J. Rossi.
2000.
Ribozyme-mediated inhibition of HIV 1 suggests nucleolar trafficking of HIV-1 RNA.
Proc. Natl. Acad. Sci. USA
97:8955-8960 |
| 42. | Mintz, P. J., S. D. Patterson, A. F. Neuwald, C. S. Spahr, and D. L. Spector. 1999. Purification and biochemical characterization of interchromatin granule clusters. EMBO J. 18:4308-4320[CrossRef][Medline]. |
| 43. | Misteli, T. 2000. Cell biology of transcription and pre-mRNA splicing: nuclear architecture meets nuclear function. J. Cell Sci. 113:1841-1849[Abstract]. |
| 44. | Misteli, T., and D. L. Spector. 1998. The cellular organization of gene expression. Curr. Opin. Cell Biol. 10:323-331[CrossRef][Medline]. |
| 45. | Muesing, M. A., D. H. Smith, C. D. Cabradilla, C. V. Benton, L. A. Lasky, and D. J. Capon. 1985. Nucleic acid structure and expression of the human AIDS/lymphadenopathy retrovirus. Nature 313:450-458[CrossRef][Medline]. |
| 46. | Nicholson, W. J., A. J. Shepherd, and D. W. Aw. 1996. Detection of unintegrated HIV type 1 DNA in cell culture and clinical peripheral blood mononuclear cell samples: correlation to disease stage. AIDS Res. Hum. Retrovir. 12:315-323[Medline]. |
| 47. | Pang, S., Y. Koyanagi, S. Miles, C. Wiley, H. V. Vinters, and I. S. Chen. 1990. High levels of unintegrated HIV-1 DNA in brain tissue of AIDS dementia patients. Nature 343:85-89[CrossRef][Medline]. |
| 48. | Pani, A., and M. E. Marongiu. 2000. Anti-HIV-1 integrase drugs: how far from the shelf? Curr. Pharm.Des. 6:569-584. |
| 49. | Panther, L. A., R. W. Coombs, J. E. Zeh, A. C. Collier, and L. Corey. 1998. Unintegrated circular HIV-1 DNA in the peripheral mononuclear cells of HIV-1-infected subjects: association with high levels of plasma HIV-1 RNA, rapid decline in CD4 count, and clinical progression to AIDS. J. Acquir. Immune Defic. Syndr. Hum. Retrovirol. 17:303-313[Medline]. |
| 50. |
Pauza, C. D.,
J. E. Galindo, and D. D. Richman.
1990.
Reinfection results in accumulation of unintegrated viral DNA in cytopathic and persistent human immunodeficiency virus type 1 infection of CEM cells.
J. Exp. Med.
172:1035-1042 |
| 51. | Plehn-Dujowich, D., P. Bell, A. M. Ishov, C. Baumann, and G. G. Maul. 2000. Non-apoptotic chromosome condensation induced by stress: delineation of interchromosomal spaces. Chromosoma 109:266-279[CrossRef][Medline]. |
| 52. | Pommier, Y., and N. Neamati. 1999. Inhibitors of human immunodeficiency virus integrase. Adv. Virus Res. 52:427-458[Medline]. |
| 53. |
Robinson, H. L., and D. M. Zinkus.
1990.
Accumulation of human immunodeficiency virus type 1 DNA in T cells: results of multiple infection events.
J. Virol.
64:4836-4841 |
| 54. |
Sakai, H.,
M. Kawamura,
J. Sakuragi,
S. Sakuragi,
R. Shibata,
A. Ishimoto,
N. Ono,
S. Ueda, and A. Adachi.
1993.
Integration is essential for efficient gene expression of human immunodeficiency virus type 1.
J. Virol.
67:1169-1174 |
| 55. |
Smith, K. P.,
P. T. Moen,
K. L. Wydner,
J. R. Coleman, and J. B. Lawrence.
1999.
Processing of endogenous pre-mRNAs in association with SC-35 domains is gene specific.
J. Cell Biol.
144:617-629 |
| 56. |
Stevenson, M.,
S. Haggerty,
C. A. Lamonica,
C. M. Meier,
S. K. Welch, and A. J. Wasiak.
1990.
Integration is not necessary for expression of human immunodeficiency virus type 1 protein products.
J. Virol.
64:2421-2425 |
| 57. | Takagi, S., K. Takada, and T. Sairenji. 1991. Formation of intranuclear replication compartments of Epstein-Barr virus with redistribution of BZLF1 and BMRF1 gene products. Virology 185:309-315[CrossRef][Medline]. |
| 58. | Vodicka, M. A., W. C. Goh, L. I. Wu, M. E. Rogel, S. R. Bartz, V. L. Schweickart, C. J. Raport, and M. Emerman. 1997. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology 233:193-198[CrossRef][Medline]. |
| 59. | Wiskerchen, M., and M. A. Muesing. 1995. Human immunodeficiency virus type 1 integrase: effects of mutations on viral ability to integrate, direct viral gene expression from unintegrated viral DNA templates, and sustain viral propagation in primary cells. J. Virol. 69:376-386[Abstract]. |
| 60. | Zack, J. A., S. J. Arrigo, S. R. Weitsman, A. S. Go, A. Haislip, and I. S. Chen. 1990. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61:213-222[CrossRef][Medline]. |
| 61. | Zazzi, M., L. Romano, M. Catucci, G. Venturi, A. De Milito, P. Almi, A. Gonnelli, M. Rubino, U. Occhini, and P. E. Valensin. 1997. Evaluation of the presence of 2-LTR HIV-1 unintegrated DNA as a simple molecular predictor of disease progression. J. Med. Virol. 52:20-25[CrossRef][Medline]. |
| 62. | Zennou, V., C. Petit, D. Guetard, U. Nerhbass, L. Montagnier, and P. Charneau. 2000. HIV-1 genome nuclear import is mediated by a central DNA flap. Cell 101:173-185[CrossRef][Medline]. |
| 63. |
Zhang, G.,
M. L. Zapp,
G. Yan, and M. R. Green.
1996.
Localization of HIV-1 RNA in mammalian nuclei.
J. Cell Biol.
135:9-18 |
This article has been cited by other articles:
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||